# A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors

> **NCT06873542** · PHASE1 · COMPLETED · sponsor: **Heronova Pharmaceuticals** · enrollment: 10 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** DC05F01

## Key facts

- **NCT ID:** NCT06873542
- **Lead sponsor:** Heronova Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-08
- **Primary completion:** 2022-12-07
- **Final completion:** 2024-01-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873542, "A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06873542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*